Profa. Dra. Ester Cerdeira Sabino

Autores

DOI:

https://doi.org/10.11606/issn.1679-9836.v99i2p213-219

Palavras-chave:

Entrevista, COVID-19, Coronavírus

Downloads

Os dados de download ainda não estão disponíveis.

Biografia do Autor

  • Ester Cerdeira Sabino, Universidade de São Paulo. Faculdade de Medicina (FMUSP). Departamento de Moléstias Infecciosas

    rofessora Associada do Departamento de Moléstias Infecciosas da Faculdade de Medicina da Universidade de São Paulo – FMUSP. Diretora do Instituto de Medicina Tropical da USP de 2015 a 2019. Investigadora principal dos programas do NIH “Recipient Epidemiology and Donor Evaluation Study-IV Pediatric” e do “São Paulo - Minas Gerais Neglected Tropical Disease Research Center for Biomarker Discovery”. Coordenadora do projeto PITE FAPESP “A Translational Study for the Identification, Characterization and Validation of Severity Biomarkers in Arboviral Infections” e do projeto FAPESP/MRC “The Brazil-UK Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology (CADDE)”. Principais linhas de pesquisas: Segurança Transfusional, HIV, Doença de Chagas, Arboviroses e Anemia Falciforme. (Fonte: CV: http://lattes.cnpq.br/8590492866942091)

Referências

World Health Organization (WHO). WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [cited 2020 April 08]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.

Yazdany J, Kim AHJ. Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know - 31 March 2020. Ann Intern Med. 2020 Mar 31. doi: 10.7326/M20-1334.

World Health Organization (WHO). “Solidarity” clinical trial for COVID-19 treatments [cited 2020 April 08]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments.

Ferguson NM, Laydon D, Nedjati-Gilani G, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team; 16 March 2020. doi: https://doi.org/10.25561/77482

Brasil. Ministério da Saúde. Saúde define critérios de distanciamento social com base em diferentes cenários [citado 08 abri. 2020]. Disponível em: https://www.saude.gov.br/noticias/agencia-saude/46666-ministerio-da-saude-define-criterios-de-distanciamento-social.

Downloads

Publicado

2020-04-23

Edição

Seção

Entrevista/Interview

Como Citar